Kaposi's sarcoma:
Indications for: PANRETIN
Cutaneous lesions of AIDS-related Kaposi's sarcoma (KS).
Adult Dosage:
Apply twice daily to lesions (avoid mucous membranes and normal skin); do not occlude; may increase to 3–4 times daily as tolerated. Reduce frequency or suspend treatment if local toxicity occurs.
Children Dosage:
Not recommended.
PANRETIN Warnings/Precautions:
Not for use when systemic KS therapy required. Avoid sun, UV light. Flammable. Pregnancy (Cat.D), nursing mothers: not recommended.
PANRETIN Classification:
Retinoid.
PANRETIN Interactions:
Increases DEET toxicity (avoid).
Adverse Reactions:
Photosensitivity, rash, pruritus, pain, exfoliative dermatitis, paresthesia, edema.
How Supplied:
Gel—60g
